{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
US Approved Rx
(2017)
Source:
BLA761055
(2017)
Source URL:
First approved in 2017
Source:
BLA761055
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2017)
Source:
BLA761037
(2017)
Source URL:
First approved in 2017
Source:
BLA761037
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2017)
Source:
BLA761040
(2017)
Source URL:
First approved in 2017
Source:
BLA761040
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2017)
Source:
BLA761032
(2017)
Source URL:
First approved in 2017
Source:
BLA761032
Source URL:
Class:
PROTEIN
Status:
US Approved Rx
(2017)
Source:
BLA761070
(2017)
Source URL:
First approved in 2017
Source:
BLA761070
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
21 CFR 347
(2017)
Source URL:
First approved in 2017
Source:
21 CFR 347
Source URL:
Class:
PROTEIN
Status:
Possibly Marketed Outside US
Source:
BLA125428
(2017)
Source URL:
First approved in 2017
Source:
BLA125428
Source URL:
Class:
NUCLEIC ACID
Status:
Possibly Marketed Outside US
Source:
505G(a)(3)
(2017)
Source URL:
First approved in 2017
Source:
505G(a)(3)
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 333D
(2019)
Source URL:
First approved in 2017
Source:
21 CFR 358H
Source URL:
Class:
POLYMER
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2018)
Source URL:
First approved in 2017
Source:
21 CFR 347
Source URL:
Class:
POLYMER